262 related articles for article (PubMed ID: 8262872)
1. Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.
de Groot HG; Hustinx PA; Lampe AS; Oosterwijk WM
J Antimicrob Chemother; 1993 Sep; 32(3):491-500. PubMed ID: 8262872
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.
Cakmakci M; Stern A; Schilling J; Christen D; Roggo A; Geroulanos S
Drugs Exp Clin Res; 1993; 19(5):223-7. PubMed ID: 8174495
[TBL] [Abstract][Full Text] [Related]
3. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections.
Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T
J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of imipenem-cilastatin versus gentamicin plus clindamycin in the treatment of polymicrobial infections.
Danziger LH; Creger RJ; Shwed JA; Stellato TA; Hau T
Pharmacotherapy; 1988; 8(6):315-8. PubMed ID: 3222164
[TBL] [Abstract][Full Text] [Related]
5. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
Eklund AE; Nord CE
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():79-85. PubMed ID: 8383657
[TBL] [Abstract][Full Text] [Related]
6. Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections.
Solomkin JS; Dellinger EP; Christou NV; Busuttil RW
Ann Surg; 1990 Nov; 212(5):581-91. PubMed ID: 2241313
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of two comparative antibiotic regimens in the treatment of serious intra-abdominal infections: results of a multicenter study.
Eckhauser FE; Knol JA; Raper SE; Mulholland MW; Helzerman P
Clin Ther; 1992; 14(1):97-109. PubMed ID: 1576632
[TBL] [Abstract][Full Text] [Related]
8. Biapenem versus imipenem/cilastatin in the treatment of complicated intra-abdominal infections: report from a Swedish Study Group.
Brismar B; Akerlund JE; Sjöstedt S; Johansson C; Törnqvist A; Bäckstrand B; Bång H; Andåker L; Gustafsson PO; Darle N; Angerås M; Falk A; Tunevall G; Kasholm-Tengve B; Skau T; Nyström PO; Gasslander T; Hagelbäck A; Olsson-Liljequist B; Eklund AE; Nord CE
Scand J Infect Dis; 1996; 28(5):507-12. PubMed ID: 8953683
[TBL] [Abstract][Full Text] [Related]
9. Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections.
Brismar B; Malmborg AS; Tunevall G; Wretlind B; Bergman L; Mentzing LO; Nyström PO; Kihlström E; Bäckstrand B; Skau T
Antimicrob Agents Chemother; 1992 Dec; 36(12):2766-73. PubMed ID: 1336347
[TBL] [Abstract][Full Text] [Related]
10. A comparison of imipenem/cilastatin with the combination of cefuroxime and metronidazole in the treatment of intra-abdominal infections.
Angerås MH; Darle N; Hamnström K; Ekelund M; Engström L; Takala J; Viste A; Holme JB
Scand J Infect Dis; 1996; 28(5):513-8. PubMed ID: 8953684
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of imipenem-cilastatin versus clindamycin+gentamicin for serious pelvic infections.
Larsen JW; Gabel-Hughes K; Kreter B
Clin Ther; 1992; 14(1):90-6. PubMed ID: 1576631
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Cefepime Intra-abdominal Infection Study Group.
Barie PS; Vogel SB; Dellinger EP; Rotstein OD; Solomkin JS; Yang JY; Baumgartner TF
Arch Surg; 1997 Dec; 132(12):1294-302. PubMed ID: 9403533
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial management of postoperative infections in abdominal surgery: single or combination regimen?
Geroulanos S; Stern A; Christen D; Buchmann P
Clin Ther; 1990; 12 Suppl B():34-42. PubMed ID: 2196121
[TBL] [Abstract][Full Text] [Related]
14. Prospective study comparing imipenem-cilastatin with clindamycin and gentamicin for the treatment of serious surgical infections.
Hackford AW; Tally FP; Reinhold RB; Barza M; Gorbach SL
Arch Surg; 1988 Mar; 123(3):322-6. PubMed ID: 3277587
[TBL] [Abstract][Full Text] [Related]
15. Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
Colardyn F; Faulkner KL
J Antimicrob Chemother; 1996 Sep; 38(3):523-37. PubMed ID: 8889726
[TBL] [Abstract][Full Text] [Related]
16. Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections.
Garau J; Blanquer J; Cobo L; Corcia S; Daguerre M; de Latorre FJ; León C; Del Nogal F; Net A; Rello J
Eur J Clin Microbiol Infect Dis; 1997 Nov; 16(11):789-96. PubMed ID: 9447899
[TBL] [Abstract][Full Text] [Related]
17. Trovafloxacin in the treatment of intra-abdominal infections: results of a double-blind, multicenter comparison with imipenem/cilastatin. Trovafloxacin Surgical Group.
Donahue PE; Smith DL; Yellin AE; Mintz SJ; Bur F; Luke DR
Am J Surg; 1998 Dec; 176(6A Suppl):53S-61S. PubMed ID: 9935258
[TBL] [Abstract][Full Text] [Related]
18. Cost-analysis of imipenem-cilastatin monotherapy compared with clindamycin+aminoglycoside combination therapy for treatment of serious lower respiratory, intra-abdominal, gynecologic, and urinary tract infections.
Kreter B
Clin Ther; 1992; 14(1):110-21. PubMed ID: 1576620
[TBL] [Abstract][Full Text] [Related]
19. Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections.
Uhari M; Seppänen J; Heikkinen E
Pediatr Infect Dis J; 1992 Jun; 11(6):445-50. PubMed ID: 1608680
[TBL] [Abstract][Full Text] [Related]
20. Imipenem-cilastatin in pediatric patients: an overview of safety and efficacy in studies conducted in the United States.
Ahonkhai VI; Cyhan GM; Wilson SE; Brown KR
Pediatr Infect Dis J; 1989 Nov; 8(11):740-4. PubMed ID: 2687787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
